In contrast, NDRG2 overexpression in 4T1 cells decreased the suppressive effect of cancer cells on CD8+ T cell proliferation (with a 4T1 cell to splenocyte ratio of 1:10) (Figure 4D). The gene discussed is NDRG2; the disease is cancer.